Evidence map›Paper›PMID 24583229›Full record

ArticleJournal of molecular biology2014

Crystal structure of the carbapenem intrinsic resistance protein CarG.

E M Tichy, B F Luisi, G P C Salmond

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. 1.8 Å resolution crystal structure of the carbapenem intrinsic resistance protein CarF.Acta crystallographica. Section D, Structural biology · 2017
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

E M TichyDepartment of Biochemistry, University of Cambridge, Building O, Downing Site, Cambridge CB21QW, UK.
B F LuisiDepartment of Biochemistry, University of Cambridge, Building O, Downing Site, Cambridge CB21QW, UK.
G P C SalmondDepartment of Biochemistry, University of Cambridge, Building O, Downing Site, Cambridge CB21QW, UK.
University of Cambridge · GB

Funding

3 D ELECTRON MICROSCOPY OF MACROMOLECULES (5P41RR002250-27)P41GM103832 · NIGMS · STANFORD UNIVERSITY · PI CHIU, WAH · 2012 to 2019
$15.1M
NIGMS NIH HHS P41 GM103832Wellcome Trust 094229
6 · The paper itself

Abstract

In the Gram-negative enterobacterium Erwinia (Pectobacterium) and Serratia sp. ATCC 39006, intrinsic resistance to the carbapenem antibiotic 1-carbapen-2-em-3-carboxylic acid is mediated by the CarF and CarG proteins, by an unknown mechanism. Here, we report a high-resolution crystal structure for the Serratia sp. ATCC 39006 carbapenem resistance protein CarG. This structure of CarG is the first in the carbapenem intrinsic resistance (CIR) family of resistance proteins from carbapenem-producing bacteria. The crystal structure shows the protein to form a homodimer, in agreement with results from analytical gel filtration. The structure of CarG does not show homology with any known antibiotic resistance proteins nor does it belong to any well-characterised protein structural family. However, it is a close structural homologue of the bacterial inhibitor of invertebrate lysozyme, PliI-Ah, with some interesting structural variations, including the absence of the catalytic site responsible for lysozyme inhibition. Both proteins show a unique β-sandwich fold with short terminal α-helices. The core of the protein is formed by stacked anti-parallel sheets that are individually very similar in the two proteins but differ in their packing interface, causing the splaying of the two sheets in CarG. Furthermore, a conserved cation binding site identified in CarG is absent from the homologue.

Indexed as

Amino Acid SequenceAnti-Bacterial AgentsBacterial ProteinsBinding SitesCarbapenemsCationsCrystallography, X-RayDrug Resistance, BacterialErwiniaModels, MolecularMolecular Sequence DataProtein ConformationProtein MultimerizationSequence AlignmentAnti-Bacterial AgentsBacterial ProteinsCarbapenemsCationsantibioticbacterial resistancecarbapenem operonCIR familylysozyme inhibitor

Identifiers

PMID24583229
PMCPMC4361734
OpenAlexW2050304812

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.